Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna P Andreou

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Cephalalgia : an International Journal of Headache|September 14, 2017
Non-invasive vagus nerve stimulation for the management of refractory primary chronic headaches: A real-world experienceMichele Trimboli, Adnan Al-Kaisy, Anna P Andreou, et al.
Toxins|April 26, 2024
Recent Developments in Engineering Non-Paralytic Botulinum Molecules for Therapeutic ApplicationsAisha Zhantleuova, Charlotte Leese, Anna P Andreou, et al.
Pain|August 21, 2012
Olvanil acts on transient receptor potential vanilloid channel 1 and cannabinoid receptors to modulate neuronal transmission in the trigeminovascular systemJan Hoffmann, Weera Supronsinchai, Anna P Andreou, et al.
Plos One|July 24, 2025
Effects and predictors of intravenous lidocaine infusion for patients with fibromyalgiaMin Liu, Stephany Harris, Anna P Andreou, et al.
Expert Review of Neurotherapeutics|March 2, 2010
Animal models of headache: from bedside to bench and back to bedsideAnna P Andreou, Oliver Summ, Annabelle R Charbit, et al.
Biomedicines|August 28, 2025
Focused Modulation of Brain Activity: A Narrative ReviewAisha Zhantleuova, Altynay Karimova, Anna P Andreou, et al.
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|June 20, 2014
Pharmacology of the capsaicin receptor, transient receptor potential vanilloid type-1 ion channelIstvan Nagy, Dominic Friston, Jojo Sousa Valente, et al.
The Journal of Headache and Pain|November 5, 2022
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysisAnna P Andreou, Matteo Fuccaro, Bethany Hill, et al.
Expert Review of Neurotherapeutics|January 30, 2025
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxisMichail Vikelis, Dimitrios Rikos, Andreas A Argyriou, et al.
Brain : a Journal of Neurology|June 2, 2016
Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraineAnna P Andreou, Philip R Holland, Simon Akerman, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Cephalalgia : an International Journal of Headache|September 14, 2017
Non-invasive vagus nerve stimulation for the management of refractory primary chronic headaches: A real-world experienceMichele Trimboli, Adnan Al-Kaisy, Anna P Andreou, et al.
Toxins|April 26, 2024
Recent Developments in Engineering Non-Paralytic Botulinum Molecules for Therapeutic ApplicationsAisha Zhantleuova, Charlotte Leese, Anna P Andreou, et al.
Pain|August 21, 2012
Olvanil acts on transient receptor potential vanilloid channel 1 and cannabinoid receptors to modulate neuronal transmission in the trigeminovascular systemJan Hoffmann, Weera Supronsinchai, Anna P Andreou, et al.
Plos One|July 24, 2025
Effects and predictors of intravenous lidocaine infusion for patients with fibromyalgiaMin Liu, Stephany Harris, Anna P Andreou, et al.
Expert Review of Neurotherapeutics|March 2, 2010
Animal models of headache: from bedside to bench and back to bedsideAnna P Andreou, Oliver Summ, Annabelle R Charbit, et al.
Biomedicines|August 28, 2025
Focused Modulation of Brain Activity: A Narrative ReviewAisha Zhantleuova, Altynay Karimova, Anna P Andreou, et al.
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|June 20, 2014
Pharmacology of the capsaicin receptor, transient receptor potential vanilloid type-1 ion channelIstvan Nagy, Dominic Friston, Jojo Sousa Valente, et al.
The Journal of Headache and Pain|November 5, 2022
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysisAnna P Andreou, Matteo Fuccaro, Bethany Hill, et al.
Expert Review of Neurotherapeutics|January 30, 2025
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxisMichail Vikelis, Dimitrios Rikos, Andreas A Argyriou, et al.
Brain : a Journal of Neurology|June 2, 2016
Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraineAnna P Andreou, Philip R Holland, Simon Akerman, et al.
Pageof 6